Pfizer - International Biopharmaceutical Industry

news

Arena, completing its turnaround, sells to Pfizer for nearly $7 billion

Pfizer has agreed to acquire Arena Pharmaceuticals for about $6.7 billion in a deal that validates the San Diego biotech’s plan to reshape itself around a portfolio o...

13 December 2021 news acquisition | Arena Pharmaceuticals

Continue Reading →

news

AbbVie’s blockbuster weighed down by safety concerns for a similar Pfizer drug

For years, AbbVie's business has relied on Humira. One of the world's top-selling medicines, Humira brought in close to $20 billion for AbbVie in each of the last thr...

10 December 2021 news ABBVIE | Humira

Continue Reading →

news

Omicron cuts Pfizer vaccine’s potency, but data show booster may restore protection

Three doses of Pfizer and BioNTech's COVID-19 vaccine may protect against the new omicron variant similarly well as two doses did against the original coronavirus str...

10 December 2021 news BioNTech | booster

Continue Reading →

news

FDA, aiming to curb another COVID-19 surge, clears Pfizer, Moderna boosters for all adults

The Food and Drug Administration on Friday authorized COVID-19 booster shots for all vaccinated Americans over 18, a move that's meant to stem a rise in coronavirus i...

26 November 2021 news boosters | COVID-19

Continue Reading →

news

Pfizer, BioNTech to seek full approval as COVID-19 vaccine efficacy holds up in young teens

The results disclosed by Pfizer and BioNTech on Monday could support full approvals in the U.S. and elsewhere, which in turn could help bolster vaccination rates amon...

26 November 2021 news BioNTech | COVID-19 vaccine

Continue Reading →

news

Pfizer will allow generic drugmakers to produce promising COVID-19 pill

Pfizer is sharing rights to make its COVID-19 pill even as it closely guards the recipe for its coronavirus vaccine, which has mostly been supplied to high- or upper ...

19 November 2021 news COVID-19 pill | generic drugmakers

Continue Reading →

news

Pfizer asks FDA to authorize COVID-19 pill

Pfizer's pill is the second oral drug for COVID-19 to be proven strongly effective in large, placebo-controlled clinical trials after Merck's molnupiravir, which earl...

19 November 2021 news clinical trials | COVID-19 pill

Continue Reading →

news

US pays $1B to nearly double supply of Merck’s COVID-19 pill

Merck is now in a race with Pfizer to capture the upside of COVID-19 pills, which could soon play an outsized role in the next phase of the pandemic and beyond. The ...

15 November 2021 news COVID-19 pill | Merck

Continue Reading →

news

Pfizer again asks FDA to authorize COVID-19 boosters for all adults

Agency advisers had opposed a broad booster dose clearance in September, leading the FDA to limit use to older adults and those at high risk of COVID-19. Pfizer and ...

15 November 2021 news adults | BioNTech

Continue Reading →

news

Pfizer buys into Biohaven’s fast-selling migraine medicine

Faced with breaking into markets led by larger companies, Biohaven turned to celebrity endorsements, Tiktok and racecar advertising to aggressively sell Nurtec ODT. I...

15 November 2021 news Biohaven | migraine

Continue Reading →